Augmedics LTD announced that it expects to receive $82.5 million in funding from CPMG, Inc., Evidity Health Capital, Revival Healthcare Capital LLC, H.I.G. Capital, LLC, Almeda Ventures Limited Partnership and other investors
June 26, 2023
Share
Augmedics LTD announced that it will receive $82,500,000 in a round of funding on June 27, 2023.
On the same date, the company has received $82,500,000 in its first tranche. The first tranche was led by new investor CPMG, Inc. and included participation from new investor, Evidity Health Capital, returning investors, H.I.G. Capital, LLC, Revival Healthcare Capital LLC, Almeda Ventures Limited Partnership, and others. Kent McGaughy from CPMG, Inc., and Paul Enever from Evidity Health Capital will join the company's board of directors. The company has raised a total of $148,000,000 in funding till date.
Almeda Ventures LP is an Israel-based investment company. The Company invests in companies active in field of research and development in the areas of digital health, medical devices and Convergence Bio. So far, the Company has invested in Bioprotect Ltd., a medical device manufacturing company operating in the area of oncology-urology, TaylorMedical Medical Ltd., Digital Health Company operating in the field of Navigation Financial (Navigation Financial), Normi Medical Ltd., instrumentation company Medicine, active in the field of tissue engineering, Mate Floo Ltd. (Lumen), digital health company operating in the field of well-being Wellness Metabolic Health Measurement and Monitoring, Virility Medical Ltd., a medical equipment company active in the field of sexual health.
Augmedics LTD announced that it expects to receive $82.5 million in funding from CPMG, Inc., Evidity Health Capital, Revival Healthcare Capital LLC, H.I.G. Capital, LLC, Almeda Ventures Limited Partnership and other investors
ALMEDA VENTURES LIMITED PARTNERSHIP 
